Association Between COVID-19 Infection and Thyroid Cancer Development: A Retrospective Cohort Study Using the TriNetX...

Area of Science:

• Endocrinology
• Oncology
• Infectious Diseases

Background:

• Coronavirus Disease 2019 (COVID-19) is associated with endocrine organ dysfunction, including the thyroid gland.
• The precise role of SARS-CoV-2 in thyroid cancer development, despite potential mechanisms like inflammation, remains unclear.
• This study aims to determine if COVID-19 infection increases the risk of developing thyroid cancer.

Purpose of the Study:

• To investigate the association between COVID-19 and the incidence of new-onset thyroid cancer.
• To identify specific patient subgroups at higher risk for thyroid cancer following COVID-19 infection.
• To explore the potential link between SARS-CoV-2 infection and thyroid oncogenesis.

Main Methods:

• A retrospective cohort study utilizing the TriNetX global federated health research database.
• Comparison of adult patients diagnosed with COVID-19 against a propensity score-matched cohort without COVID-19.
• Exclusion of patients with prior thyroid cancer history or COVID-19 vaccination, with new-onset thyroid cancer diagnosed at least one year post-COVID-19.

Main Results:

• A significantly higher incidence of thyroid cancer was observed in the post-COVID-19 group compared to the non-COVID-19 group.
• Increased thyroid cancer risk was noted in male patients post-COVID-19 (HR 1.22).
• Patients with post-COVID-19 hyperthyroidism (HR 2.14) or hypothyroidism (HR 1.83) showed a significantly higher risk of thyroid cancer.

Conclusions:

• COVID-19 infection is associated with an elevated risk of thyroid cancer development.
• Male patients and individuals experiencing thyroid dysfunction after COVID-19 are at a particularly increased risk.
• Findings suggest a potential role for SARS-CoV-2 in thyroid oncogenesis, necessitating further investigation.